Analyzing Competitive Technologies (OTCMKTS:CTTC) and Electromed (NYSE:ELMD)

Competitive Technologies (OTCMKTS:CTTC – Get Free Report) and Electromed (NYSE:ELMD – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, earnings, institutional ownership, risk and profitability.

Analyst Ratings

This is a breakdown of current ratings for Competitive Technologies and Electromed, as provided by MarketBeat.

Electromed has a consensus price target of $37.50, suggesting a potential downside of 11.54%. Given Competitive Technologies’ higher possible upside, equities research analysts clearly believe Competitive Technologies is more favorable than Electromed.

Valuation & Earnings

This table compares Competitive Technologies and Electromed”s revenue, earnings per share and valuation.

Electromed has higher revenue and earnings than Competitive Technologies.

Institutional & Insider Ownership

40.8% of Electromed shares are held by institutional investors. 17.5% of Competitive Technologies shares are held by company insiders. Comparatively, 10.5% of Electromed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Profitability

This table compares Competitive Technologies and Electromed’s net margins, return on equity and return on assets.

Summary

Electromed beats Competitive Technologies on 7 of the 9 factors compared between the two stocks.

About Competitive Technologies

(Get Free Report)

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.

About Electromed

(Get Free Report)

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.